Clinical Pharmacology Study of CHF1535 pMDI 50/6 µg Versus The Free Combination In Asthmatic Children 5-11 Years Old

NCT01848769 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: CHF1535 pMDI + AC Plus
DRUG: BDP + AC Plus
DRUG: Formoterol + AC Plus

Sponsor

Chiesi Farmaceutici S.p.A.